Quarterly report pursuant to sections 13 or 15(d)

Document And Entity Information

v2.4.0.8
Document And Entity Information
9 Months Ended
Sep. 30, 2013
Nov. 14, 2013
Document Information [Line Items]    
Entity Registrant Name MusclePharm Corp  
Entity Central Index Key 0001415684  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol MSLP  
Entity Common Stock, Shares Outstanding   8,865,990
Document Type 10-Q  
Amendment Flag true  
Document Period End Date Sep. 30, 2013  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2013  
Amendment Description The sole purpose of this Amendment No. 2 (this “Amendment”) to MusclePharm Corporation’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2013, filed with the Securities and Exchange Commission on November 14, 2013 and subsequently amended on November 15, 2013 (the “Form 10-Q”) is to correct an error in the calculation of sales concentration by customer for the nine months ended in Note 2 of the Consolidated Financial Statements.  Specifically, Note 2, Subsection “Revenue Recognition” was changed to indicate that the percent of sales for the three largest customers for the three and nine months ended September 30, 2013 were as follows: Three Months Ended September 30, Customer 2013 2012 A 32 % 37 % B 10 % 8 % C 9 % 7 % Nine Months Ended September 30, Customer 2013 2012 A 30 % 39 % B 11 % 8 % C 7 % 10 % The previously disclosed calculation of the three largest customers for the nine months ended was 28%, 9%, and 5%, respectively.  The calculations are based on gross customer sales as a percent of gross sales for the applicable period. No other modifications or changes have been made to the Form 10-Q. This Amendment speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date and does not modify or update in any way disclosures made in the original Form 10-Q.